Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.785
0.00 (0.00%)
May 21, 2026, 10:52 AM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 81.54 million as of May 21, 2026. Its market cap has decreased by -0.46% in one year.
Market Cap
81.54M
Enterprise Value
65.65M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.79
Market Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 81.54M, a decrease of -43.53%. That is a compound annual growth rate of -11.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 84.97M | -1.99% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | 144.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Magle Chemoswed Holding AB | 118.99M |
| NextCell Pharma AB | 118.30M |
| IRLAB Therapeutics AB | 106.00M |
| Annexin Pharmaceuticals AB | 105.18M |
| AcouSort AB | 103.28M |
| Biovica International AB | 101.29M |
| Scandinavian ChemoTech AB | 92.40M |
| OncoZenge AB | 91.03M |